Insider Buying: Venture Life Group (LON:VLG) Insider Acquires 14,760 Shares of Company Stock

by · The Markets Daily

Venture Life Group plc (LON:VLG – Get Free Report) insider Daniel Wells acquired 14,760 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The shares were bought at an average cost of GBX 68 per share, for a total transaction of £10,036.80.

Daniel Wells also recently made the following trade(s):

  • On Wednesday, September 30th, Daniel Wells purchased 38,717 shares of Venture Life Group stock. The shares were bought at an average price of GBX 65 per share, for a total transaction of £25,166.05.

Venture Life Group Price Performance

Shares of VLG stock traded up GBX 3.50 during trading hours on Thursday, reaching GBX 69. The stock had a trading volume of 1,029,339 shares, compared to its average volume of 276,889. The stock’s fifty day simple moving average is GBX 67.41 and its 200 day simple moving average is GBX 65.09. The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. Venture Life Group plc has a 12 month low of GBX 52 and a 12 month high of GBX 72. The firm has a market capitalization of £82.83 million, a PE ratio of 15.79, a PEG ratio of 5.67 and a beta of 0.23.

Venture Life Group (LON:VLG – Get Free Report) last released its quarterly earnings results on Tuesday, September 29th. The company reported GBX 4.10 EPS for the quarter. Venture Life Group had a net margin of 17.42% and a return on equity of 7.82%. On average, equities research analysts predict that Venture Life Group plc will post 6.1391542 EPS for the current year.

Venture Life Group Company Profile

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.

Further Reading